Both endocrinologists and oncologists need to look out for this rare endocrine side effect of some MEK inhibitors particularly in patients with vasopressin deficiency/ diabetes insipidus. We report on the 6th case. journals.lww.com/jpho-online/...
journals.lww.com
Trametinib-Induced Hyponatremia in a Patient With... : Journal of Pediatric Hematology/Oncology
r of MEK1 and MEK2, which has been evaluated in both adult and pediatric cancers/ tumors with activation of the oncogenic mitogen-activated protein kinase (MAPK) pathway. Despite being thought to have...